Guanosine selectively inhibits locomotor stimulation induced by the NMDA antagonist dizocilpine

Behavioural Brain Research

Volumn 154, Issue 2, 2004, Pages 417-422

  Tort, Adriano B L ^a   Mantese, Carlos E ^a   Dos Anjos, Gabriel M ^a   Dietrich, Marcelo O ^a   Dall'Igna, Oscar P ^a   Souza, Diogo O ^a   Lara, Diogo R ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Amphetamine; Caffeine; Guanosine; Locomotion; MK 801; Schizophrenia

Indexed keywords

ADENOSINE RECEPTOR BLOCKING AGENT; AMPHETAMINE; CAFFEINE; DIZOCILPINE; DOPAMINE RECEPTOR STIMULATING AGENT; GUANOSINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ARTICLE; ATTENUATION; CONTROLLED STUDY; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TASK PERFORMANCE; WORKING MEMORY;

AMPHETAMINE; ANIMALS; BEHAVIOR, ANIMAL; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; GUANOSINE; LOCOMOTION; MALE; MAZE LEARNING; MICE; MOTOR ACTIVITY; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 4143108308     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2004.03.008     Document Type: Article

References (33)

1. Abi-Saab W.M., D'Souza D.C., Moghaddam B., Krystal J.H. The NMDA antagonist model for schizophrenia: promise and pitfalls. Pharmacopsychiatry. 31(S2):1998;104-109
2. Adams B., Moghaddam B. Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine. J Neurosci. 18(14):1998;5545-5554
3. Adams B.W., Moghaddam B. Effect of clozapine, haloperidol, or M100907 on phencyclidine-activated glutamate efflux in the prefrontal cortex. Biol Psychiatry. 50(10):2001;750-757
4. Adams B.W., Bradberry C.W., Moghaddam B. NMDA antagonist effects on striatal dopamine release: microdialysis studies in awake monkeys. Synapse. 43(1):2002;12-18
5. Anderson C.M., Swanson R.A. Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia. 32(1):2000;1-14
6. Baron B.M., Dudley M.W., McCarty D.R., Miller F.P., Reynolds I.J., Schmidt C.J. Guanine nucleotides are competitive inhibitors of N-methyl-D-aspartate at its receptor site both in vitro and in vivo. J. Pharmacol. Exp. Ther. 250:1989;162-169
7. Cartmell J., Monn J.A., Schoepp D.D. The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus D-amphetamine motor behaviors in rats. J. Pharmacol. Exp. Ther. 291(1):1999;161-170
8. Deutsch S.I., Rosse R.B., Billingslea E.N., Bellack A.S., Mastropaolo J. Topiramate antagonizes MK-801 in an animal model of schizophrenia. Eur J Pharmacol. 449(1/2):2002;121-125
9. Danbolt N.C. Glutamate uptake. Prog. Neurobiol. 65(1):2001;105
10. Frizzo M.E.S., Lara D.R., Dahm K.C.S., Prokopiuk A.S., Swanson R.A., Souza D.O. Activation of glutamate uptake by guanosine in primary astrocyte cultures. NeuroReport. 12:2001;879-881
11. Frizzo M.E.S., Lara D.R., Prokopiuk A.S., Vargas C.R., Salbego C.G., Wajner M., et al. Guanosine enhances glutamate uptake in brain cortical slices at normal and excitotoxic conditions. Cell. Mol. Neurobiol. 22:2002;353-363
12. Frizzo M.E.S., Soares F.A.A., Dall'Onder L.P., Lara D.R., Swanson R.A., Souza D.O. Extracellular conversion of guanine-based purines to guanosine specifically enhances astrocyte glutamate uptake. Brain Res. 972:2003;84-89
13. Hauber W., Andersen R. The non-NMDA glutamate receptor antagonist GYKI 52466 counteracts locomotor stimulation and anticataleptic activity induced by the NMDA antagonist dizocilpine. Naunyn Schmiedebergs Arch. Pharmacol. 348(5):1993;486-490
14. Izquierdo I., Medina J.H. Memory formation: the sequence of biochemical events in the hippocampus and its connection to activity in other brain structures. Neurobiol. Learn. Memory. 68:1997;285-316
15. Jedema H.P., Moghddam B. Characterization of excitatory amino acid modulation of dopamine release in the prefrontal cortex of conscious rats. J. Neurochem. 66(4):1996;1448-1453
16. Kreschtemer B.D. NMDA receptor antagonist induced dopamine release in the ventral pallidium does not correlate with minor motor activation. Brain Res. 859:2000;147-156
17. Lara D.R., Schmidt A.P., Frizzo M.E.S., Burgos J.S., Ramirez G., Souza D.O. Effect of orally administered guanosine on seizures and death induced by glutamatergic agents. Brain Res. 912:2001;176-180
18. Loeffler D.A., Camp D.M., Juneau P.L., Harel E., LeWitt P.A. Purine-induced alterations of dopamine metabolism in rat pheochromocytoma PC12 cells. Brain Res. Bull. 52(6):2000;553-558
19. Malcon C., Achaval M., Komlos F., Partata W., Sauressig M., Ramírez G., et al. GMP protects against quinolinic acid-induced loss of NADPH-diaphorase-positive cells in the rat striatum. Neurosci. Lett. 225:1997;145-148
20. Moghaddam B., Adams B., Verma A., Daly D. Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci. 17(8):1997;2921-2927
21. Moghaddam B, Adams BW. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science 1998;28;281(5381):1349- 52.
22. O'Neill M.F., Shaw G. Comparison of dopamine receptor antagonists on hyperlocomotion induced by cocaine, amphetamine, MK-801 and the dopamine D1 agonist C-APB in mice. Psychopharmacology (Berl). 145(3):1999;237-250
23. Paas Y., Devillers-Thiery A., Changeux J.P., Medevielle F., Teichberg V.I. Identification of an extracellular motif involved in the binding of guanine nucleotides by a glutamate receptor. EMBO J. 15:1996;1548-1556
24. Paz M.M., Ramos M., Ramirez G., Souza D. Differential effects of guanine nucleotides on kainic acid binding and on adenylate cyclase activity in chick optic tectum. FEBS Lett. 355:1994;205-208
25. Rathbone M.P., Middlemiss P.J., Gysbers J.W., Andrew C., Herman M.A., Reed J.K., et al. Trophic effects of purines in neurons and glial cells. Prog. Neurobiol. 59:1999;663-690
26. Roesler R., Vianna M.R.M., Lara D.R., Izquierdo I., Schmidt A.P., Souza D.O. Guanosine impairs inhibitory avoidance performance in rats. NeuroReport. 11:2000;2537-2540
27. Schmidt A.P., Lara D.R., Maraschin J.F., Perla A.S., Souza D.O. Guanosine and GMP prevent seizures induced by quinolinic acid in mice. Brain Res. 864:2000;40-43
28. Souza D.O., Ramirez G. Effects of guanine nucleotides on KA binding and on adenylate cyclase activity in optic tectum and cerebellum of chicken. J. Mol. Neurosci. 3:1991;39-46
29. Souza D.O., Frizzo M.E.S., Lara D.R. Glutamate uptake enhanced by guanosine in vitro: possible neuroprotective mechanism against hypoxia/hypoglycemia injury. Drug Dev. Res. 50:2000;115
30. Takahata R., Moghaddam B. Target-specific glutamatergic regulation of dopamine neurons in the ventral tegmental area. J. Neurochem. 75(4):2000;1775-1778
31. Takahata R., Moghaddam B. Activation of glutamate neurotransmission in the prefrontal cortex sustains the motoric and dopaminergic effects of phencyclidine. Neuropsychopharmacology. 28(6):2003;1117-1124
32. Velakoulis D., Wood S.J., McGorry P.D., Pantelis C. Evidence for progression of brain structural abnormalities in schizophrenia: beyond the neurodevelopmental model. Aust. N.Z. J. Psychiatry. 34:2000;S113-S126
33. Vinadé E.R., Schmidt A.P., Frizzo M.E.S., Izquierdo I., Elisabetsky E., Souza D.O. Chronically administered guanosine is anticonvulsant, amnesic and anxiolytic in mice. Brain Res. 977(1):2003;97-102